The COVID-19 pandemic exposed the truth of something the lab industry has known and publicly stated repeatedly for over a decade: The FDA is ill-equipped to regulate Laboratory Developed Tests (LDTs) … [Read more...]
FDA
FDA Clears the Way for Over-the-Counter Sale of COVID-19 Home Test Kits
February 19, 2021
Since the pandemic began, the FDA has granted Emergency Use Authorization (EUA) for more than 250 COVID-19 diagnostic tests. Among these, nearly 30 have received clearance for at-home collection; a … [Read more...]
FDA
FDA Sounds Alarm on Potential Impact of Genetic Mutation on SARS-CoV-2 Molecular Test Accuracy
January 30, 2021
As if COVID-19 testing wasn’t challenging enough, the emergence of new variants has made the SARS-CoV-2 virus a moving target. With this in mind, the FDA is warning clinical labs and health care … [Read more...]
FDA
FDA Clears the Way for Over-the-Counter Sale of COVID-19 Home Test Kits
January 30, 2021
Since the pandemic began, the FDA has granted Emergency Use Authorization (EUA) for more than 250 COVID-19 diagnostic tests. Among these, 25 have received clearance for at-home collection; a couple … [Read more...]
FOCUS ON
What a Biden Administration Might Portend for Regulation of Laboratory Developed Tests
November 17, 2020
The roller coaster that has become FDA regulation of laboratory developed tests (LDTs) is about to get even more topsy-turvy now that Joseph Biden has been elected President of the United States. … [Read more...]
HHS Announcement
The FDA Drops a Bombshell: No More EUA Review of COVID-19 LDTs
October 19, 2020
Perhaps one of the only positive things to come out of the COVID-19 crisis has been its exposure of the flaws in the FDA’s ham-handed system (if it can be called a system) of premarket regulation of … [Read more...]
EUA
FDA to Issue Emergency Use Authorization for Multi-Analyte Respiratory Panels During the Pandemic
September 17, 2020
The convergence of flu season with the global COVID-19 pandemic will create the need for new multi-analyte respiratory panel tests that are capable of not only detection of but also differentiation … [Read more...]
LDTs
FDA Breaks New Ground by Authorizing SARS-CoV-2 Tests for Sample Pooling
September 8, 2020
It’s not uncommon for the FDA to revise the Emergency Use Authorization (EUA) for a particular diagnostics test to permit a new clinical use. In most cases, these expansions don’t even get an official … [Read more...]
FDA Watch
FDA Warns of False-Positives from Becton Dickinson SARS-CoV-2 Test & Reagents
July 20, 2020
July 6 was a tough day for Becton Dickinson (BD) when the FDA issued a warning letter alerting clinical lab staff and providers of the increased risk of false-positive results from the New … [Read more...]
LDTs
FDA Provides New Guidance on Validation of Sample Pooling for SARS-CoV-2 Test Development
July 20, 2020
On June 16, the FDA issued new guidance to help labs and commercial manufacturers use test sample pooling to develop, validate and acquire Emergency Use Authorization (EUA) of qPCR-based SARS-CoV-2 … [Read more...]
